Patients with obesity and normal menstrual cycles exhibited well-controlled LH levels when using CC for COH, demonstrating a significantly lower incidence of LH >10 IU/L compared to normal-weight patients. This evidence concerns the gene PLOD1 and obesity due to melanocortin 4 receptor deficiency.